sec filings
Insider trades
Open-market buys and sales that company insiders report to the SEC on .
Side
Planned sales
Role
ELVN
Updated 10/6/2026, 8:56 AM ET.
| Stock | Side | Value | Insider | Shares | Avg price | Filed | Tags | Filing |
|---|---|---|---|---|---|---|---|---|
| ELVN Enliven Therapeutics, Inc. | Sale | $606,719 | Garland J. Scott Director | 13,000 sh | at $46.67 | Filed Oct 5, 4:57 PM ET | Filing | |
| ELVN Enliven Therapeutics, Inc. | Sale | $303,003 | Hohl Benjamin CHIEF FINANCIAL OFFICER | 6,018 sh | at $50.35 | Filed Sep 21, 5:23 PM ET | Filing | |
| ELVN Enliven Therapeutics, Inc. | Sale | $251,754 | Collins Helen Louise CHIEF MEDICAL OFFICER | 5,000 sh | at $50.35 | Filed Sep 21, 5:22 PM ET | Filing | |
| ELVN Enliven Therapeutics, Inc. | Sale | $352,551 | Hohl Benjamin CHIEF FINANCIAL OFFICER | 6,018 sh | at $58.58 | Filed Aug 19, 4:17 PM ET | Filing | |
| ELVN Enliven Therapeutics, Inc. | Sale | $292,931 | Collins Helen Louise CHIEF MEDICAL OFFICER | 5,000 sh | at $58.59 | Filed Aug 19, 4:16 PM ET | Filing | |
| ELVN Enliven Therapeutics, Inc. | Sale | $9,561,587 | Derynck Mika K Director | 158,795 sh | at $60.21 | Filed Aug 6, 8:18 PM ET | Filing | |
| ELVN Enliven Therapeutics, Inc. | Sale | $316,780 | Hohl Benjamin CHIEF FINANCIAL OFFICER | 6,018 sh | at $52.64 | Filed Jul 21, 5:24 PM ET | Filing | |
| ELVN Enliven Therapeutics, Inc. | Sale | $263,373 | Collins Helen Louise CHIEF MEDICAL OFFICER | 5,000 sh | at $52.67 | Filed Jul 21, 5:23 PM ET | Filing | |
| ELVN Enliven Therapeutics, Inc. | Sale | $504,903 | Kunkel Lori Anne Director | 10,000 sh | at $50.49 | Filed Jul 8, 5:15 PM ET | Filing |